(5-methyl-2,4,6-trioxo-1,3-diazinan-5-yl)oxycarbamic acid
C6H7N3O6 — CID 138629132
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5-methyl-2,4,6-trioxo-1,3-diazinan-5-yl)oxycarbamic acid
(5-methyl-2,4,6-trioxo-1,3-diazinan-5-yl)oxycarbamic acid (PubChem CID 138629132) has the molecular formula C6H7N3O6 and a molecular weight of 217.14 g/mol. Its IUPAC name is (5-methyl-2,4,6-trioxo-1,3-diazinan-5-yl)oxycarbamic acid.
Molecular Properties
| Compound Name | (5-methyl-2,4,6-trioxo-1,3-diazinan-5-yl)oxycarbamic acid |
|---|---|
| PubChem CID | 138629132 |
| Molecular Formula | C6H7N3O6 |
| Molecular Weight | 217.14 g/mol |
| Exact Mass | 217.03 |
| IUPAC Name | (5-methyl-2,4,6-trioxo-1,3-diazinan-5-yl)oxycarbamic acid |
| SMILES | CC1(ONC(=O)O)C(=O)NC(=O)NC1=O |
| InChI | InChI=1S/C6H7N3O6/c1-6(15-9-5(13)14)2(10)7-4(12)8-3(6)11/h9H,1H3,(H,13,14)(H2,7,8,10,11,12) |
| InChIKey | UOSHCVRHYGCGHT-UHFFFAOYSA-N |
| XLogP | -1.69 |
| TPSA | 133.83 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 15 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 217.14 |
| LogP ≤ 5 | -1.69 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138629132 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.